Cargando…

Topical Calcineurin Inhibitors: Expanding Indications for Corneal and Ocular Surface Inflammation

Detalles Bibliográficos
Autores principales:	Ghasemi, Hamed, Djalilian, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KNOWLEDGE E 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825691/ https://www.ncbi.nlm.nih.gov/pubmed/31875093 http://dx.doi.org/10.18502/jovr.v14i4.5435

Ejemplares similares

Keratoconus; a True Corneal Disease
por: Ghassembaglou, Navid, et al.
Publicado: (2016)

Treatment of pruritic diseases with topical calcineurin inhibitors
por: Ständer, Sonja, et al.
Publicado: (2006)

Topical calcineurin inhibitors in systemic lupus erythematosus
por: Lampropoulos, Christos E, et al.
Publicado: (2010)

Novel Diagnostic and Therapeutic Methods in Ocular Surface and Corneal Diseases
por: Nowinska, Anna K., et al.
Publicado: (2017)

The Ocular Surface Chemical Burns
por: Eslani, Medi, et al.
Publicado: (2014)

Latest Treatment Option and Technology Advancement in Corneal and Ocular Surface Disease
por: Costagliola, Ciro, et al.
Publicado: (2014)

Advancing beyond our recent advances in ocular surface disease and corneal surgery
por: Jeng, Bennie H.
Publicado: (2023)

Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
por: Sticherling, Michael
Publicado: (2011)

Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations
por: Carr, Warner W.
Publicado: (2013)

Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia
por: Ghaffari, Reza, et al.
Publicado: (2021)

Ocular Inflammation
por: Huerva, Valentín, et al.
Publicado: (2015)

Topical Calcineurin Inhibitors and Lymphoma Risk: Evidence Update with Implications for Daily Practice
por: Siegfried, Elaine C., et al.
Publicado: (2013)

Reflectance Confocal Microscopy in Monitoring Atopic Dermatitis Treated with Topical Calcineurin Inhibitors
por: Bratu, Dalia, et al.
Publicado: (2023)

Calcineurin/CXCR4 in T-ALL
por: Passaro, Diana, et al.
Publicado: (2015)

Special Issue “Diagnosis and Management of Dry Eye Disease and Ocular Surface Inflammation”
por: Giannaccare, Giuseppe, et al.
Publicado: (2022)

Ocular Inflammation and Infection
por: Callegan, Michelle, et al.
Publicado: (2012)

Ocular Examination and Corneal Surface Disease in the Ferret
por: Myrna, Kathern E., et al.
Publicado: (2019)

Calcineurin Inhibitors in Lung Donors to Attenuate Ischemia–Reperfusion Injury in Recipients: Next Steps?
por: Rozenberg, Dmitry, et al.
Publicado: (2022)

Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use
por: Gutfreund, Katarzyna, et al.
Publicado: (2013)

Ocular surface tumors
por: Varde, Meghana Anika, et al.
Publicado: (2009)

Characterization of Ex Vivo Expanded Oral Mucosal Epithelium Cells on Acellular Porcine Corneal Stroma for Ocular Surface Reconstruction
por: Wang, Jia-Song, et al.
Publicado: (2017)

Application of biomaterials and nanotechnology in corneal tissue engineering
por: Soleimani, Mohammad, et al.
Publicado: (2023)

Thermogels containing sulfated hyaluronan as novel topical therapeutics for treatment of ocular surface inflammation
por: Nguyen, Duc Dung, et al.
Publicado: (2021)

Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs
por: Lerche, Catharina M., et al.
Publicado: (2010)

CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults
por: Segal, Audrey O, et al.
Publicado: (2013)

Anti‐inflammatory potency testing of topical corticosteroids and calcineurin inhibitors in human volunteers sensitized to diphenylcyclopropenone
por: Mose, Kristian F., et al.
Publicado: (2018)

Comparison of Therapeutic Effects of Topical Calcineurin Inhibitor and Moisturizing Cream on Pruritic External Auditory Canal
por: Lee, Sang-Yeon, et al.
Publicado: (2021)

Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Facial and Genital Psoriasis: A Systematic Review
por: AMIRI, Diva, et al.
Publicado: (2023)

Expanding Indications of Gastric Electrical Stimulation
por: Oh, Jung Hwan
Publicado: (2015)

Clinical associations of corneal neuromas with ocular surface diseases
por: Toh, Charmaine Jan Li, et al.
Publicado: (2023)

Calcineurin Inhibitors and COVID-19
por: Hage, René, et al.
Publicado: (2022)

Calcineurin Inhibitors in Membranous Nephropathy
por: Ponticelli, Claudio, et al.
Publicado: (2021)

Calcineurin Inhibitors and COVID-19
por: Hage, René, et al.
Publicado: (2022)

Ocular Surface Infection and Antimicrobials
por: Dutta, Debarun, et al.
Publicado: (2022)

Characteristics of corneal phospholipidosis induced by topical ocular application of chloroquine and amiodarone in rabbits
por: Yamagiwa, Yoshinori, et al.
Publicado: (2016)

Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis
por: Siegfried, Elaine C., et al.
Publicado: (2016)

Expanding indications of full endoscopic spine surgery
por: Gadjradj, Pravesh S., et al.
Publicado: (2023)

Efficacy and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis: meta-analysis of randomized clinical trials
por: £abędź, Natalia, et al.
Publicado: (2019)

Improvement of chronic corneal opacity in ocular surface disease with prosthetic replacement of the ocular surface ecosystem (PROSE) treatment
por: Cressey, Anna, et al.
Publicado: (2018)

Topical Cyclosporine A for Mustard Gas Induced Ocular Surface Disorders
por: Jadidi, Khosrow, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ctrug6lq8vo6ljuhobo99v87as